IBM Shares Jump in Premarket on New Anthropic AI Partnership
IBM stock climbed 7% in premarket trading after announcing a deal with Anthropic to bring Claude AI to its software suite.
BTC$59,066.00-1.70%
ETH$1,560.18-0.92%
USDT$0.9985+0.00%
USDC$0.99970.00%
XRP$1.04-1.16%
SOL$70.43-0.51%
TRX$0.322+0.48%
FIGR_HELOC$1.04+0.64%
HYPE$60.81-2.54%
DOGE$0.0727-2.56%
USDS$0.9995+0.00%
RAIN$0.0155-0.41%
LEO$9.42+0.44%
ZEC$370.03-6.54%
XMR$310.37-0.81%
BTC$59,066.00-1.70%
ETH$1,560.18-0.92%
USDT$0.9985+0.00%
USDC$0.99970.00%
XRP$1.04-1.16%
SOL$70.43-0.51%
TRX$0.322+0.48%
FIGR_HELOC$1.04+0.64%
HYPE$60.81-2.54%
DOGE$0.0727-2.56%
USDS$0.9995+0.00%
RAIN$0.0155-0.41%
LEO$9.42+0.44%
ZEC$370.03-6.54%
XMR$310.37-0.81%
Tesla’s valuation continues to defy traditional metrics, powered less by car sales and more by Elon Musk’s mythos and the company’s steady transformation into an AI infrastructure giant.
IBM stock climbed 7% in premarket trading after announcing a deal with Anthropic to bring Claude AI to its software suite.
IREN stock climbed in premarket after announcing new AI cloud deals and GPU deployments targeting over $500 million in 2026 revenue.
APP shares dropped after reports of an SEC probe into its data practices and potential breaches of platform agreements.
Lockheed’s defense backlog, Pfizer’s biotech expansion, and Schlumberger’s energy contracts make for safe and potentially lucrative dividend plays heading into year-end.
ACHR shares climbed more than 7% Monday on renewed Tesla partnership buzz.
CRML stock surged after reports the U.S. may take a stake in its Greenland rare earths project.
AMD stock climbed over 20% after announcing a major AI chip partnership with OpenAI.
Plug Power stock surged over 250% since May on analyst upgrades and record hydrogen output.
RCAT stock climbed after a $172.5M raise, an AI drone deal, and new defense orders.
USAR shares jumped after CEO confirmed White House talks, topping $25 in premarket trading.
ANRO stock rose over 6% in premarket after the FDA granted Fast Track status to ALTO-101, its schizophrenia drug candidate.
QBTS shares surged on a $400M equity raise and real-world quantum applications.